Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy of Oral Tofacitinib in Moderate to Severe Alopecia Areata, Totalis and Universalis at Tertiary Care Hospital, Karachi.

NCT06278402 is registered in ClinicalTrials.gov with Jinnah Hospital as lead sponsor.

NCT NCT06278402
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06278402 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy of Oral Tofacitinib in Moderate to Severe Alopecia Areata, Totalis and Universalis at Tertiary Care Hospital, Karachi.
Lead sponsor
Jinnah Hospital
Phase
Phase 3
Overall status
Completed
Start date
July 1, 2023
Completion date
January 16, 2024
Enrollment
30 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

alopecia areata, alopecia totalis, alopecia universalis